Stingray Therapeutics has a total of 32 patents globally, out of which 5 have been granted. Of these 32 patents, more than 75% patents are active. Europe (EPO) is where Stingray Therapeutics has filed the maximum number of patents, followed by United States of America and South Korea. Parallelly, the
Plexium has a total of 51 patents globally, out of which 11 have been granted. Of these 51 patents, more than 84% patents are active. The United States is where Plexium has filed the maximum number of patents, followed by China. Parallelly, the US seems to be the main focused
Aleta Biotherapeutics has a total of 119 patents globally, out of which 8 have been granted. Of these 119 patents, more than 63% patents are active. The United States is where Aleta Biotherapeutics has filed the maximum number of patents, followed by Japan and Mexico. Parallelly, the United States seems
ImmunoGenesis has a total of 56 patents globally, out of which 41 have been granted. Of these 56 patents, more than 83% patents are active. The United States is where ImmunoGenesis has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, the US seems to be
Radiance Therapeutics has a total of 46 patents globally, out of which 7 have been granted. Of these 46 patents, more than 78% patents are active. The United States is where Radiance Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, the USA seems
DevaCell has a total of 10 patents globally, out of which 3 have been granted. Of these 10 patents, more than 50% patents are active. The USA & Europe (EPO) is where DevaCell has filed the maximum number of patents. Parallelly, the United States seems to be the main focused
NovaBiotics has a total of 378 patents globally, out of which 184 have been granted. Of these 378 patents, more than 93% patents are active. The USA is where NovaBiotics has filed the maximum number of patents, followed by Europe (EPO) and United Kingdom. Parallelly, the UK seems to be
Gila Therapeutics has a total of 24 patents globally, out of which none have been granted. Of these 24 patents, more than 70% patents are active. The USA is where Gila Therapeutics has filed the maximum number of patents. Parallelly, the United States seems to be the main focused R&D
Synthekine has a total of 168 patents globally, out of which 4 have been granted. Of these 168 patents, more than 80% patents are active. Europe (EPO) is where Synthekine has filed the maximum number of patents, followed by Canada. Parallelly, the USA seems to be the main focused R&D
Tremeau Pharmaceuticals has a total of 39 patents globally, out of which 7 have been granted. Of these 39 patents, more than 74% patents are active. The USA is where Tremeau Pharmaceuticals has filed the maximum number of patents, followed by Canada and Japan. Parallelly, the USA seems to be
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.